{domain:"www.qualitydigest.com",server:"169.47.211.87"} Skip to main content

User account menu
Main navigation
  • Topics
    • Customer Care
    • FDA Compliance
    • Healthcare
    • Innovation
    • Lean
    • Management
    • Metrology
    • Operations
    • Risk Management
    • Six Sigma
    • Standards
    • Statistics
    • Supply Chain
    • Sustainability
    • Training
  • Videos/Webinars
    • All videos
    • Product Demos
    • Webinars
  • Advertise
    • Advertise
    • Submit B2B Press Release
    • Write for us
  • Metrology Hub
  • Training
  • Subscribe
  • Log in
Mobile Menu
  • Home
  • Topics
    • 3D Metrology-CMSC
    • Customer Care
    • FDA Compliance
    • Healthcare
    • Innovation
    • Lean
    • Management
    • Metrology
    • Operations
    • Risk Management
    • Six Sigma
    • Standards
    • Statistics
    • Supply Chain
    • Sustainability
    • Training
  • Login / Subscribe
  • More...
    • All Features
    • All News
    • All Videos
    • Contact
    • Training

Federal Regulators ‘Patent’ Another Bad Idea

Unexamined patent applications stack up due to filched funds

Michael Causey
Wed, 06/05/2013 - 16:48
  • Comment
  • RSS

Social Sharing block

  • Print
  • Add new comment
Body

The shell game called the federal budget added another nut recently as media reports revealed that during the last 20 years, approximately $1 billion in fees paid by patent applicants has been diverted from its proper use at the United States Patent Office (USPTO).

ADVERTISEMENT

Critics argue that, as a self-funded agency, USPTO should not be impacted by the “sequester” game of chicken both sides of the aisle are playing.

The Medical Device Manufacturers Association (MDMA) slammed the USPTO fund shift in a May 31, 2013, letter to lawmakers charging, “This unwarranted diversion of fees has resulted in more than 600,000 unexamined patent applications and more than 31 months in the average patent pendency time—the wait time from a patent application’s filing until final action on the application by the USPTO.”

MDMA praised former USPTO Director David Kappos for making significant progress toward fixing this mess, but worried that those steps in the right direction would be blocked if, “once again USPTO fees do not remain at the USPTO.”

 …

Want to continue?
Log in or create a FREE account.
Enter your username or email address
Enter the password that accompanies your username.
By logging in you agree to receive communication from Quality Digest. Privacy Policy.
Create a FREE account
Forgot My Password

Comments

Submitted by Timelord on Wed, 06/12/2013 - 03:43

Deepfreezer

They're just in the fridge for future (ab)use.

Albert Einstein worked also in a patent office.

  • Reply

Add new comment

Image CAPTCHA
Enter the characters shown in the image.
Please login to comment.
      

© 2025 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute Inc.

footer
  • Home
  • Print QD: 1995-2008
  • Print QD: 2008-2009
  • Videos
  • Privacy Policy
  • Write for us
footer second menu
  • Subscribe to Quality Digest
  • About Us
  • Contact Us